ANNEX FORM TO EXAMINE THE CAUSES OF ESRD I IDENTIFICATION. 1 Record number (patient chart) Name. 1.1 Date of birth / / 1.2 Sex:

Similar documents
THE KIDNEY AND SLE LUPUS NEPHRITIS

Professor Suetonia Palmer

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study

4. resisted training ** OR resistance training * OR resisted exercise ** OR resistance exercise ** OR strength training ** OR strength exercise **

A factorial randomized trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

Educational Goals & Objectives

ACOFP 55th Annual Convention & Scientific Seminars. How Complicated is Your Panel? Effective Risk Coding in Primary Care. Alison Mancuso, DO, FACOFP

Supplement materials:

Chapter 4: Cardiovascular Disease in Patients With CKD

USRDS UNITED STATES RENAL DATA SYSTEM

Blood Pressure Treatment Goals

Stages of Chronic Kidney Disease (CKD)

Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care

IHA P4P Measure Manual Measure Year Reporting Year 2018

Supplemental Table 1. Standardized Serum Creatinine Measurements. Supplemental Table 3. Sensitivity Analyses with Additional Mortality Outcomes.

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

DIABETES MEASURES GROUP OVERVIEW

Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

HEDIS QUICK REFERENCE GUIDE: DOCUMENTATION TIPS FOR ADULT MEASURES

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus

ATTENDING PHYSICIAN'S STATEMENT CORONARY ARTERY BY-PASS SURGERY or OTHER SERIOUS CORONARY ARTERY DISEASE

DIABETES MELLITUS. Kidney in systemic diseases. Slower the progression: Pathology: Patients with diabetes mellitus are prone to other renal diseases:

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Managing Chronic Kidney Disease: Reducing Risk for CKD Progression

Supplementary Online Content

Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes

Protecting the heart and kidney: implications from the SHARP trial

ADVANCE post trial ObservatioNal Study

M2 TEACHING UNDERSTANDING PHARMACOLOGY

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease

Diabetes and Hypertension

QBPC Claims Based Provider Quick Reference Guide

Supplement Table 1. Definitions for Causes of Death

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

Complications of Diabetes: Screening and Prevention. Dr Martin McIntyre Consultant Physician Royal Alexandra Hospital Paisley

CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN 2007

Guideline on the clinical management of Henoch Schonlein Purpura (HSP)

Supplementary Appendix

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

WCHQ MEASURES AT A GLANCE

Case 3. ACCME/Disclosure. Laboratory results. Clinical history 4/13/2016

ICD-10-AM/ACHI/ACS Eighth Edition. HIMAA/NCCH Conference Renal workshop October 2014

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Primary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

CKD & HT. Anne-Marie Angus

ADPedKD: detailed description of data which will be collected in this registry

Supplementary Online Content

Diabetes Complications Guideline Based Screening, Management, and Referral

Definitions of chronic conditions used to define the number of serious comorbidities in the study.

ICD-10CM, HCC and Risk Adjustment Factor

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

USRDS UNITED STATES RENAL DATA SYSTEM

We know these take time to gather, so please plan ahead!

SCOTTISH REAL BIOPSY REGISTRY: SURVEY OF NATIVE KIDNEY BIOPSY IN SCOTLAND 2015

Chapter 9: Cardiovascular Disease in Patients With ESRD

REFERRAL GUIDELINES: RENAL MEDICINE

Chronic Kidney Disease (CKD) and egfr: Decision and Dilemma. Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

Chapter 37: Exercise Prescription in Patients with Diabetes

Predicting and changing the future for people with CKD

Complications of Diabetes: Screening and Prevention

For more information about how to cite these materials visit

Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use

ACUTE KIDNEY INJURY A PRIMER FOR PRIMARY CARE PHYSICIANS. Myriam Farah, MD, FRCPC

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better?

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL

Coronary Heart Disease

INTRODUCTION. In this study we examined the

Macrovascular Residual Risk. What risk remains after LDL-C management and intensive therapy?

Potentially Preventable Hospitalizations

Diabetes Overview. How Food is Digested

Chronic Benefit Application Form Cardiovascular Disease and Diabetes

ATTENDING PHYSICIAN'S STATEMENT KIDNEY FAILURE / SURGICAL REMOVAL OF ONE KIDNEY OR CHRONIC KIDNEY DISEASE

Update on HIV-Related Kidney Diseases. Agenda

SUPPLEMENTARY DATA. Table of Contents

CKD IN THE CLINIC. Session Content. Recommendations for commonly used medications in CKD. CKD screening and referral

HIHIM Clinical Cocepts for Managers 7/31/2009. Fernando Vega, MD 1

2008 Dialysis Facility Report

Case #1. Current Management Strategies in Chronic Kidney Disease. Serum creatinine cont. Pitfalls of Serum Cr

How complicated is diabetes? Jonathan Shaw

EVIDENCE BASED TREATMENT OF IgA NEPHROPATHY. Jonathan Barratt

SAIL documentation SUMMIT

WCHQ MEASURES AT A GLANCE

Hanyang University Guri Hospital Chang Beom Lee

For Office Use Only: MA complete Date of Visit / / mm/dd/yyyy. This form must be scanned into the medical record. Do not remove from clinic.

Hypertension targets: sorting out the confusion. Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis

Chronic Kidney Disease. Dr Mohan B. Biyani A. Professor of Medicine University of Ottawa/Ottawa Hospital

6 UROLOGICAL CANCERS. 6.1 Key Points

Patient enrolment details CKDOD registry

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

American Diabetes Association Standards of Medical Care in Diabetes 2017: Focus on Complications

Egyptian Hypertension Guidelines

Transcription:

Supplementary Material from Prevalence of clinically validated primary causes of end-stage renal disease (ESRD) in a State Capital in Northeastern Brazil ANNEX FORM TO EXAMINE THE CAUSES OF ESRD I IDENTIFICATION 1 Record number (patient chart) Name 1.1 Date of birth / / 1.2 Sex: 1. Male ( ) 2. Female ( ) 1.3 Dialysis start date at the unit: / / II DIAGNOSIS 2 Primary disease listed on the patient chart: 2.1 ICD-10: III BASIS FOR DIAGNOSIS: Clinical factors: 3 Nephrotic syndrome: 4 Urolithiasis: 1

5 Prolonged use of nephrotoxic drugs: 5.1 Drug name(s) 6 Prolonged use of illegal drugs: 6.1 Specify: 7 Obstructive urologic symptoms: 7.1 Other factors: 8. Is there a family history of kidney disease? 8.1 Specify: A. Imaging: 9. Ultrasound: 9.1 If yes, kidney size: 0 normal ( ) 1 decreased ( ) 2 unknown ( ) 4 normal ( ) 9.2 1 L kidney 2 R kidney 3 Not applicable ( ) 9.3 OTHER (MRI, CT) 10 Kidney biopsy: 2

If yes: 10.1 Date of biopsy: 10.2 Specify: 3 Not applicable ( ) 11 Antibodies 11.1 ANCA 11.2 ANA 11.3 DNA No ( ) 1 Yes ( ) 11.4 Outros No ( ) 1 Yes ( ) 11.4.1 Specify: 3 Not applicable ( ) 11.5 Protein electrophoresis: No ( ) 1 Yes ( ) 11.6 Angiogram No ( ) 1 Yes ( ) 11.6.1 Result (arteriogram/mra): 3 Not applicable ( ) B. Hypertension/Diabetes: 12 Treatment for hypertension 12.1 Highest systolic BP on record 3

12.2 Highest diastolic BP on record 12.3 Is there evidence of accelerated hypertension (grade III/IV retinopathy)? 13 Is/was the patient diabetic? IF YES, if NO, score as: 3 Not applicable ( ) 13.1 1 DM type I ( ) 2 DM type II ( ) Other 13.2 Age at diagnosis (years): 13.3 Has the patient been treated with insulin? 13.4 Time diagnosed with DM at the start of insulin therapy (years) 14 Was there proteinuria? 14.1 Maximum level: 3 Not applicable ( ) 14.2 Was there macroscopic hematuria? 14.3 Was there microscopic hematuria? 15 Was there any evidence of target-organ injury? 4

Microvascular Retinopathy ( ) Hypertension ( ) Diabetes ( ) GI-II ( ) GIII-IV ( ) N-prolif ( ) Prolif. ( ) Neuropathy ( ) Not specified ( ) Macrovascular Cerebrovascular Stroke ( ) Hemorrhagic TIA ( ) Stroke ( ) stroke ( ) Coronary AMI ( ) Angina ( ) Revascularization ( ) Peripheral vascular Grafts ( ) Amputations ( ) RLL ( ) LLL ( ) Toe ( ) Other ( ) C. Supplementary information 16 Day when the patient first presented with kidney disease / / 17 Day when creatinine > 1.0 (fem)/1.3 (male) for the first time / / 18 Day when the patient was first referred to a nephrologist / / 19 Day of first renal replacement therapy session / / 20 Has the patient ever undergone emergency hemodialysis? 21 Creatinine level at first renal replacement therapy session: 0 No ( ) 5

D. Summarized baseline disease diagnosis: 22. Diagnosis: 0 No ( ) 3 Not applicable ( ) 22.1 Primary: 22.2 ICD-10: 23 Comorbidities: ( ) 23.1.1 ICD-10: 23.2.1 ICD-10: 24. Did the diagnosis in the patient chart agree with the validated diagnosis? 0 No ( ) 1 Yes ( ) 25. Validated diagnosis 0 No ( ) 1 Yes ( ) 3 Not applicable ( ) If not: 25.1 Primary: 25.2 Comorbidities: 25.2.1 ICD-10 6